EUVIMEDEUVIMED entdecken
Open Access

PLEKHA4 knockdown induces apoptosis in melanoma cells through the MAPK and β‑catenin signaling pathways

Yuyang Yue, Guangqi An, Shuxia Cao, Xiangdan Li, Liping Du, Dongyuan Xu, Lan Liu

Molecular Medicine Reports · 2025

DOI: 10.3892/mmr.2025.13464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Medicine Reports, 2025. Verfasst von Yuyang Yue und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yanbian University Hospital, Yanji, Jilin 133000, P.R. China. Hauptthemen laut MEDLINE: Melanoma, Apoptosis, Wnt Signaling Pathway, beta Catenin. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant melanoma (MM) is a highly aggressive subtype of skin cancer characterized by a poor prognosis, particularly in the advanced stages. Despite advancements in targeted therapy and immunotherapy, the survival rates for MM remain low, underscoring the need for new therapeutic targets. Pleckstrin homology domain‑containing family A member 4 (PLEKHA4), which has regulatory functions in pivotal cellular processes, has emerged as a potential target in melanoma. The present study aimed to investigate the role of PLEKHA4 in melanoma progression, focusing on its influence on the MAPK and Wnt/β‑catenin signaling pathways. Bioinformatics analysis revealed that PLEKHA4 was upregulated in melanoma tissues, whereas PLEKHA4 knockdown in melanoma cell lines (A375 and A2058) significantly inhibited cell proliferation and migration, enhanced apoptosis and inhibited tumor growth in vivo. Mechanistic studies demonstrated that PLEKHA4 may exert its effects by modulating the MAPK signaling pathway through interactions with key proteins, including ERK, JNK and MEK. Additionally, PLEKHA4 was shown to impact apoptosis by regulating caspase‑3, COX2 and p65. Additionally, β‑catenin nuclear translocation was affected via the Wnt pathway. Moreover, PLEKHA4 knockdown reduced cMyc ubiquitination, consequently promoting its degradation. The present findings suggested that PLEKHA4 could promote melanoma cell proliferation by regulating both the MAPK and Wnt/β‑catenin pathways, thereby proposing PLEKHA4 as a promising therapeutic target for MM. Further studies are warranted to elucidate the mechanisms underlying PLEKHA4‑mediated modulation of cMyc ubiquitination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaApoptosisWnt Signaling Pathwaybeta CateninMAP Kinase Signaling SystemHumansCell Line, TumorCell ProliferationAnimalsMiceGene Knockdown TechniquesCell MovementGene Expression Regulation, NeoplasticFemaleMale

Stichwörter der Autor:innen

MAPKWnt/β‑cateninapoptosiscMycmelanomapleckstrin homology domain‑containing family A member 4

Substanzen

beta Catenin

Autor:innen und Institutionen

  • Department of Pathology, Yanbian University Hospital, Yanji, Jilin 133000, P.R. China.
  • Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
  • Key Laboratory of Cellular Function and Pharmacology of Jilin Province, Medical College of Yanbian University, Yanji, Jilin 133002, P.R. China.
  • Center of Morphological Experiment, Medical College of Yanbian University, Yanji, Jilin 133002, P.R. China.

Zitieren

APA

Yue, Y., An, G., Cao, S., Li, X., Du, L., Xu, D., & Liu, L. (2025). PLEKHA4 knockdown induces apoptosis in melanoma cells through the MAPK and β‑catenin signaling pathways. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2025.13464

Vancouver

Yue Y, An G, Cao S, Li X, Du L, Xu D, et al. PLEKHA4 knockdown induces apoptosis in melanoma cells through the MAPK and β‑catenin signaling pathways. Molecular Medicine Reports. 2025. doi:10.3892/mmr.2025.13464

BibTeX
@article{Yue2025,
  author = {Yue, Yuyang and An, Guangqi and Cao, Shuxia and Li, Xiangdan and Du, Liping and Xu, Dongyuan and Liu, Lan},
  title = {PLEKHA4 knockdown induces apoptosis in melanoma cells through the MAPK and β‑catenin signaling pathways},
  journal = {Molecular Medicine Reports},
  year = {2025},
  doi = {10.3892/mmr.2025.13464}
}
Kostenlos starten →